Echocardiographic Evaluation of the Effect of Dapagliflozin on Epicardial Adipose Tissue and Left Ventricular Systolic Function in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus
J Diabetes Complicat 2023 May 18;37(7)108509, XT Song, YL Wei, YF Rui, L FanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.